The Application of Real-World Evidence in Regulatory Decision Making
Cerise James, MD, moderates this podcast in which Neil Belson, JD, discusses Real World Evidence and its impact to the biopharmaceutical industry.
Cerise James, MD, moderates this podcast in which Neil Belson, JD, discusses Real World Evidence and its impact to the biopharmaceutical industry.
Real-World Evidence can show safety and effectiveness per FDA’s “totality of evidence approach” for evaluating regulatory submissions.
This Medical Affairs Professional Society (MAPS) podcast features medical affairs thought leaders offering insights into the Medical Affairs strategic planning process
Murali Gopal, MD, discusses the power of Integrated Brand Planning to transform the Medical Affairs function within the biopharmaceutical industry
Sawyer is making it her life’s work to focus on the patient—the most important stakeholder in drug development.
MAPS speaks with Beat Sümegi, SVP Medical with Sanofi, about major areas of change and the need to help Medical Affairs professionals build new skills to succeed in this world of increased responsibility and opportunity.
External medical education demands are continuously evolving, and MA needs to continue to evolve with these changes to establish effective education strategies.
What is company and medical affairs led education and how it is perceived by audience? What are the different perspectives existing among regulators, Pharma and agencies? What is the potential for disease state medical education by medical affairs?
OBJECTIVES: Identify the major trends and drivers towards digital transformation and drive Medical Affairs towards a digital future.
This article provides an overview of the new MedTech European regulatory environment and opportunities for the Medical Affairs function to evolve and bring value to the respective organizations.